Napa Parinyanitikul

7PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursGene and molecular therapyClinical midwiferyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 01, 2026
Feasibility and Preliminary Effectiveness of the ChulaCancer Mobile Chatbot for Supportive Care of Patients With Breast or Colorectal Cancer Receiving Chemotherapy: Pilot Randomized Controlled Trial.

|May 07, 2026
The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.

|May 04, 2026
Transdermal Delivery of Sonidegib via Iontophoresis from PEDOT:PSS/Gelatin Hydrogels for Basal Cell Carcinoma Skin Cancer.

|Nov 14, 2025
Clinical Outcomes of HER2-Low Versus HER2-Zero in HR-Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study.

Thiti Susiriwatananont, Concord Wongkraisri, Thanate Dajsakdipon

|Jun 03, 2022
Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories.

Suthinee Ithimakin, Napa Parinyanitikul, Sung-Bae Kim

|Dec 07, 2018
Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer.

Shuying Liu, Shunqiang Li, Bailiang Wang

Pageof 2

Frequent Collaborators

3 joint publications

Thiti Susiriwatananont

2 joint publications

Chanida Vinayanuwattikun

2 joint publications

Suthinee Ithimakin

2 joint publications

Piyada Sitthideatphaiboon